HAEMONETICS CORP (HAE) › Capital ExpendituresHAEMONETICS CORP (HAE) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $56.38M2010: $56.30M2011: $46.67M2012: $53.20M2013: $62.19M2014: $73.65M2015: $122.22M2016: $102.41M2017: $76.14M2018: $74.80M2019: $118.96M2020: $48.76M2021: $37.04M2022: $96.51M2023: $191.33M2024: $38.12M2025: $39.28M2026: $32.78M$32.78M2009Capital Expenditures (USD)2026Fiscal YearCapital ExpendituresChange YoY2026$32.78M-16.5%2025$39.28M+3.0%2024$38.12M-80.1%2023$191.33M+98.2%2022$96.51M+160.6%2021$37.04M-24.0%2020$48.76M-59.0%2019$118.96M+59.0%2018$74.80M-1.8%2017$76.14M-25.7%2016$102.41M-16.2%2015$122.22M+66.0%2014$73.65M+18.4%2013$62.19M+16.9%2012$53.20M+14.0%2011$46.67M-17.1%2010$56.30M-0.1%2009$56.38M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share